Zepp Health R&D Spending Growth & History (ZEPP)

Zepp Health's r&d spending was $45.3M for fiscal 2025.

View full Zepp Health company overview

Zepp Health annual r&d spending history

Zepp Health annual r&d spending

Fiscal yearPeriod endedR&D spendingChangeGrowth
20252025-12-31$45.3M−$841,000−1.82%
20242024-12-31$46.2M−$5.3M−10.38%
20232023-12-31$51.5M−$25.8M−33.37%
20222022-12-31$77.3M−$3.5M−4.37%
20212021-12-31$80.8M−$1.6M−1.97%
20202020-12-31$82.5M$20.6M+33.24%
20192019-12-31$61.9M$23.6M+61.64%
20182018-12-31$38.3M$14.6M+61.93%
20172017-12-31$23.6M

Zepp Health r&d spending trends

Over the last five fiscal years, Zepp Health's r&d spending decreased from $82.5M to $45.3M, a change of −$37.1M. The latest reported quarter, Q2 2026, shows $11.5M.

About the metric

What research and development spending means

Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.

Calculation and source

SEC-reported R&D expense

TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Zepp Health source filings ↗

Community posts

It’s quiet here.

No posts about ZEPP yet. Start the conversation.

Write the first post